Your browser doesn't support javascript.
loading
Elevated C-reactive protein level is associated with poor prognosis in follicular lymphoma patients undergoing rituximab-containing chemotherapy.
Kawaguchi, Yukiko; Saito, Bungo; Nakata, Ayaka; Matsui, Tomoharu; Sasaki, Yohei; Shimada, Shotaro; Abe, Maasa; Watanuki, Megumi; Baba, Yuta; Murai, So; Arai, Nana; Fujiwara, Shun; Kabasawa, Nobuyuki; Tsukamoto, Hiroyuki; Uto, Yui; Yanagisawa, Kouji; Hattori, Norimichi; Harada, Hiroshi; Nakamaki, Tsuyoshi.
Afiliação
  • Kawaguchi Y; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan. kawaguchi.y@med.showa-u.ac.jp.
  • Saito B; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
  • Nakata A; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
  • Matsui T; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
  • Sasaki Y; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
  • Shimada S; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
  • Abe M; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
  • Watanuki M; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
  • Baba Y; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
  • Murai S; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
  • Arai N; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
  • Fujiwara S; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
  • Kabasawa N; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
  • Tsukamoto H; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
  • Uto Y; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
  • Yanagisawa K; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
  • Hattori N; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
  • Harada H; Division of Hematology, Department of Medicine, Showa University Fujigaoka Hospital, Kanagawa, Japan.
  • Nakamaki T; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
Int J Hematol ; 112(3): 341-348, 2020 Sep.
Article em En | MEDLINE | ID: mdl-32524308
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína C-Reativa / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Folicular / Rituximab Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína C-Reativa / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Folicular / Rituximab Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article